Patents by Inventor Elizabeth CORWIN

Elizabeth CORWIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • System and method for implementing an interbank information network
    Patent number: 11972399
    Abstract: The invention relates to creating a secure, decentralized, cloud-based network or physical/virtual infrastructure that enables the payments industry to redefine payment processing and information sharing. The innovative network addresses key pain points by reducing payment delays and touch points, realizing faster and comprehensive payment tracking, real-time sanctions, AML and fraud management tools.
    Type: Grant
    Filed: February 19, 2019
    Date of Patent: April 30, 2024
    Assignee: JPMORGAN CHASE BANK, N.A.
    Inventors: John Corwin Hunter, Palka S. Patel, Luciane Sant'Anna, Leticia Pui Sze Lim, Tiffany Ashley Wan, Elizabeth Polanco Aquino, Samer Falah, Sudhir Upadhyay, Tulasi Movva, Suresh Shetty
  • System and method for implementing an interbank information network
    Patent number: 11966886
    Abstract: The invention relates to creating a secure, decentralized, cloud-based network or physical/virtual infrastructure that enables the payments industry to redefine payment processing and information sharing. The innovative network addresses key pain points by reducing payment delays and touch points, realizing faster and comprehensive payment tracking, real-time sanctions, AML and fraud management tools.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: April 23, 2024
    Assignee: JPMORGAN CHASE BANK, N.A.
    Inventors: John Corwin Hunter, Palka S. Patel, Luciane Sant'Anna, Leticia Pui Sze Lim, Tiffany Ashley Wan, Elizabeth Polanco Aquino, Samer Falah, Sudhir Upadhyay, Tulasi Movva, Suresh Shetty
  • HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF BREAST CANCER
    Publication number: 20240076402
    Abstract: Methods for using anti-LIV1 antibodies, including drug conjugated anti-LIV1 antibodies, to inhibit proliferation of a LIV-1-expressing cell, as well as for the treatment of one or more diseases or disorders associated with LIV-1-expressing cells (e.g., a LIV-1-associated breast cancer), are provided.
    Type: Application
    Filed: March 7, 2023
    Publication date: March 7, 2024
    Inventors: Dana KENNEDY, Ana KOSTIC, Elizabeth CORWIN, Jonathan DRACHMAN, Peter HAUGHNEY, Baiteng ZHAO, Phillip GARFIN, Maria Corinna PALANCA-WESSELS, Oyewale O. ABIDOYE
  • HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF BREAST CANCER
    Publication number: 20200283540
    Abstract: Methods for using anti-LIV1 antibodies, including dmg conjugated anti-LIV1 antibodies, to inhibit proliferation of a LIV-1-expressing cell, as well as for the treatment of one or more diseases or disorders associated with LIV-1-expressing cells (e.g., a LIV-1-associated breast cancer), are provided.
    Type: Application
    Filed: November 30, 2018
    Publication date: September 10, 2020
    Inventors: Dana KENNEDY, Ana KOSTIC, Elizabeth CORWIN, Jonathan DRACHMAN, Peter HAUGHNEY, Baiteng ZHAO, Phillip GARFIN, Corinna PALANCA-WESSELS, Oyewale O. ABIDOYE